In the worst of cases, it is hard for me to envision that the promising BoM and Cell data, a coveted BTD, library of molecules & IP, and $400-500m in tax loss credits aren't worth at least $1b to some BP down the road in a fire sale if RVX continually flounders and can't raise money in the future. Eventually, RVX or some "savage" bargain hunting BP will make something of this technology. My question is if I will still be alive at that time haha. 

Best case is for this Covid trial to get underway and either prove something, or learn something valuable (Covid is mutating and not going away soon). The train is stopped on the tracks again at the moment, need some motion, and positivity to get the pps and larger interest cycling again.